Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Nuray Çakici
Observed names:
N. Cakici,
N. Çakici,
Çakici, N.
Institutions:
Amsterdam UMC Location University of Amsterdam,
Parnassia Groep,
Amsterdam Neuroscience,
Amsterdam University Medical Centers,
Parnassia Groep Academie
Observed institutions:
Erasmus MC,
Amsterdam UMC Location University of Amsterdam,
Parnassia Groep,
Amsterdam Neuroscience,
Antes,
Amsterdam University Medical Centers,
Parnassia Groep Academie,
University of Amsterdam,
Erasmus University Rotterdam
show all 9
ORCID:
0000-0003-3142-0107
Observed ORCID:
0000-0003-3142-0107
OpenAlex ID:
A5023446190
An update on the efficacy of anti-inflammatory agents for patients with schizophrenia: a meta-analysis
2019
·
N. Çakici
, N. J. M. van Beveren
, et al.
·
Psychological Medicine
·
236
PDF
Altered peripheral blood compounds in drug-naïve first-episode patients with either schizophrenia or major depressive disorder: a meta-analysis
2020
·
Nuray Çakici
, Arjen L. Sutterland
, et al.
·
Brain Behavior and Immunity
·
177
PDF
Systematic review of treatments for diabetic peripheral neuropathy
2016
·
N. Çakici
, T. M. Fakkel
, et al.
·
Diabetic Medicine
·
152
Changes in peripheral blood compounds following psychopharmacological treatment in drug-naïve first-episode patients with either schizophrenia or major depressive disorder: a meta-analysis
2021
·
Nuray Çakici
, Arjen L. Sutterland
, et al.
·
Psychological Medicine
·
41
PDF
Increased serum levels of leptin and insulin in both schizophrenia and major depressive disorder: A cross-disorder proteomics analysis
2019
·
Nuray Çakici
, Mariska Bot
, et al.
·
European Neuropsychopharmacology
·
40
Risk Factors for Developing Diabetic Peripheral Neuropathy: a Meta-analysis
2020
·
Tirzah M. Fakkel
, Nuray Çakici
, et al.
·
SN Comprehensive Clinical Medicine
·
20
PDF
Potential benefits of ketone therapy as a novel immunometabolic treatment for schizophrenia
2025
·
Karin Huizer
, Shubham Soni
, et al.
·
Psychiatry Research
·
3
PDF
Cross-sectional association between metabolic parameters and psychotic-like experiences in a population-based sample of middle-aged and elderly individuals
2023
·
Nuray Çakici
, Nina H. Grootendorst-van Mil
, et al.
·
Schizophrenia Research
·
2
Predictive biomarkers for negative symptoms in schizophrenia
2021
·
N. Cakici
, L. De Haan
, et al.
·
European Psychiatry
·
1
PDF
Peripheral blood compounds in schizophrenia and major depressive disorder
2025
·
Çakici, N.
·
Pure Amsterdam UMC
PDF
Anti-inflammatory Agents for Patients with Schizophrenia
2021
·
Nico J. M. van Beveren
, Nuray Çakici
, et al.
·
Springer eBooks
Reply to interleukin-6 in schizophrenia: Cause of death matters
2020
·
Nuray Çakici
, Arjen L. Sutterland
, et al.
·
Brain Behavior and Immunity
O10.7. SIMILARLY ALTERED PROTEIN MARKERS IN DRUG-NAïVE FIRST-EPISODE PATIENTS WITH SCHIZOPHRENIA OR MAJOR DEPRESSIVE DISORDER. A META-ANALYSIS
2019
·
Nuray Çakici
, Arjen L Sutterland
, et al.
·
Schizophrenia Bulletin
T68. Subclinical Psychotic Phenomena Are Associated With Markers of an Altered Metabolism in a Large Community Sample
2019
·
Nuray Çakici
, Nina H van Mill
, et al.
·
Schizophrenia Bulletin
PDF
Show more works
View as search
Works count:
14
Citation count:
672
H-index:
6
I10-index:
6
Year
Topic
Type